9,10-anthraquinone has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH; Bae, EJ; Bae, MA; Chi, YI; Choi, WI; Dighe, M; Gim, HE; Jaladi, AK; Jang, YK; Jeon, JH; Jeon, YH; Jung, KY; Kim, M; Lee, D; Lee, GH; Lee, IK; Lee, KM; Lee, S; Lee, T; Liu, KH; Pagire, HS; Pagire, SH; Park, S; Song, JS; Yoo, EK | 1 |
1 other study(ies) available for 9,10-anthraquinone and Metabolic Diseases
| Article | Year |
|---|---|
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
Topics: Administration, Oral; Animals; Anthraquinones; Binding Sites; Cell Line; Half-Life; Humans; Hypoglycemic Agents; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Microsomes, Liver; Molecular Docking Simulation; Obesity; Protein Kinase Inhibitors; Protein Kinases; Rats; Structure-Activity Relationship | 2019 |